Lupus nephritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Krzys617 (talk | contribs)
nocaptcha
701 edits
Anmol Pitliya (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators, Widget editors
9,217 edits
No edit summary
Line 7: Line 7:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
===Prevalence===
===Prevalence===
{| class="wikitable"
{| class="wikitable"
Line 27: Line 30:
|}
|}


===Case Fatality Rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
===Gender===
Females are more commonly affected with Lupus nephritis. With an overall female to male ratio of approximately 8:1 in adults and 4:3 in children.<ref name="pmid278213903">{{cite journal| author=Almaani S, Meara A, Rovin BH| title=Update on Lupus Nephritis. | journal=Clin J Am Soc Nephrol | year= 2017 | volume= 12 | issue= 5 | pages= 825-835 | pmid=27821390 | doi=10.2215/CJN.05780616 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27821390  }}</ref>  
Females are more commonly affected with Lupus nephritis. With an overall female to male ratio of approximately 8:1 in adults and 4:3 in children.<ref name="pmid278213903">{{cite journal| author=Almaani S, Meara A, Rovin BH| title=Update on Lupus Nephritis. | journal=Clin J Am Soc Nephrol | year= 2017 | volume= 12 | issue= 5 | pages= 825-835 | pmid=27821390 | doi=10.2215/CJN.05780616 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27821390  }}</ref>  

Revision as of 20:37, 31 January 2018

Lupus nephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lupus nephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lupus nephritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lupus nephritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lupus nephritis epidemiology and demographics

CDC on Lupus nephritis epidemiology and demographics

Lupus nephritis epidemiology and demographics in the news

Blogs on Lupus nephritis epidemiology and demographics

Directions to Hospitals Treating Lupus nephritis

Risk calculators and risk factors for Lupus nephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

Systemic Lupus Erythematosus (per 100,000)[1]
North America[2] 4.8 to 78.5
Europe[3] 25 to 91
Australia[4] 19 to 63
Japan[5] 8 to 18
China[6] 30 to 50

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

Females are more commonly affected with Lupus nephritis. With an overall female to male ratio of approximately 8:1 in adults and 4:3 in children.[7]

Race

African Americans have a higher frequency of developing Lupus nephritis in the United States.[8]

Frequency rate %[9]
Caucasian 29
Asian 40-82
Hispanic 61
Black 69

Developing Countries

Developed Countries

References

  1. ↑ Almaani S, Meara A, Rovin BH (2017). "Update on Lupus Nephritis". Clin J Am Soc Nephrol. 12 (5): 825–835. doi:10.2215/CJN.05780616. PMID 27821390.
  2. ↑ Danchenko N, Satia JA, Anthony MS (2006). "Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden". Lupus. 15 (5): 308–18. doi:10.1191/0961203306lu2305xx. PMID 16761508 PMID: 16761508 Check |pmid= value (help).
  3. ↑ Danchenko N, Satia JA, Anthony MS (2006). "Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden". Lupus. 15 (5): 308–18. doi:10.1191/0961203306lu2305xx. PMID 16761508 PMID: 16761508 Check |pmid= value (help).
  4. ↑ Danchenko N, Satia JA, Anthony MS (2006). "Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden". Lupus. 15 (5): 308–18. doi:10.1191/0961203306lu2305xx. PMID 16761508 PMID: 16761508 Check |pmid= value (help).
  5. ↑ Osio-Salido E, Manapat-Reyes H (2010). "Epidemiology of systemic lupus erythematosus in Asia". Lupus. 19 (12): 1365–73. doi:10.1177/0961203310374305. PMID 20947544 PMID: 20947544 Check |pmid= value (help).
  6. ↑ Osio-Salido E, Manapat-Reyes H (2010). "Epidemiology of systemic lupus erythematosus in Asia". Lupus. 19 (12): 1365–73. doi:10.1177/0961203310374305. PMID 20947544 PMID: 20947544 Check |pmid= value (help).
  7. ↑ Almaani S, Meara A, Rovin BH (2017). "Update on Lupus Nephritis". Clin J Am Soc Nephrol. 12 (5): 825–835. doi:10.2215/CJN.05780616. PMID 27821390.
  8. ↑ Almaani S, Meara A, Rovin BH (2017). "Update on Lupus Nephritis". Clin J Am Soc Nephrol. 12 (5): 825–835. doi:10.2215/CJN.05780616. PMID 27821390.
  9. ↑ Almaani S, Meara A, Rovin BH (2017). "Update on Lupus Nephritis". Clin J Am Soc Nephrol. 12 (5): 825–835. doi:10.2215/CJN.05780616. PMID 27821390.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Lupus_nephritis_epidemiology_and_demographics&oldid=1435898"